31. Filosto S, Fry W, Knowlton AA, Goldkorn T (2010) Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B). J Biol Chem 285: 10213–10222. 32. Sot J, Ibarguren M, Busto JV, Montes LR, Goni FM, et al. (2008) Cholesterol displacement by ceramide in sphingomyelin-containing liquid-ordered domains, and generation of gel regions in giant lipidic vesicles. FEBS Lett 582: 3230–3236. 33. Chung BM, Raja SM, Clubb RJ, Tu C, George M, et al. (2009) Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src. BMC Cell Biol 10: 84. 34. Chung BM, Dimri M, George M, Reddi AL, Chen G, et al. (2009) The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene 28: 1821–1832. 35. Ise N, Omi K, Miwa K, Honda H, Higashiyama S, et al. (2010) Novel monoclonal antibodies recognizing the active conformation of epidermal growth factor receptor. Biochem Biophys Res Commun 394: 685–690. 36. Pike LJ, Casey L (2002) Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 41: 10315–10322. 37. Byfield FJ, Aranda-Espinoza H, Romanenko VG, Rothblat GH, Levitan I (2004) Cholesterol depletion increases membrane stiffness of aortic endothelial cells. Biophys J 87: 3336–3343. 38. Megha, London E (2004) Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem 279: 9997–10004. 39. Megha, Sawatzki P, Kolter T, Bittman R, London E (2007) Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts). Biochim Biophys Acta 1768: 2205–2212. 40. Chan C, Goldkorn T (2000) Ceramide path in human lung cell death. Am J Respir Cell Mol Biol 22: 460–468. 41. Lavrentiadou SN, Chan C, Ravid T, Tsaba A, van der Vliet A, et al. (2001) Ceramide-Mediated Apoptosis in Lung Epithelial Cells Is Regulated by GSH. Am J Respir Cell Mol Biol 25: 676–684. 42. Castillo SS, Levy M, Thaikoottathil JV, Goldkorn T (2007) Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp Cell Res 313: 2680–2686. 43. Denu JM, Tanner KG (1998) Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633–5642. 44. Lee SR, Kwon KS, Kim SR, Rhee SG (1998) Reversible inactivation of protein- tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366–15372. 45. Xu Y, Tan LJ, Grachtchouk V, Voorhees JJ, Fisher GJ (2005) Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. J Biol Chem 280: 42694–42700. 46. Reynolds AR, Tischer C, Verveer PJ, Rocks O, Bastiaens PI (2003) EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol 5: 447–453. 47. Kim H, Chan R, Dankort DL, Zuo D, Najoukas M, et al. (2005) The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Oncogene 24: 7599–7607. 48. Shtiegman K, Kochupurakkal BS, Zwang Y, Pines G, Starr A, et al. (2007) Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene 26: 6968–6978. EGFR Activation under Oxidative Stress 49. Yang CH (2008) EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. Lung Cancer 60 Suppl 2: S23–30. 50. Goldman R, Levy RB, Peles E, Yarden Y (1990) Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29: 11024–11028. 51. Harris LN, Yang L, Liotcheva V, Pauli S, Iglehart JD, et al. (2001) Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy. Clin Cancer Res 7: 1497–1504. 52. Ni CY, Yuan H, Carpenter G (2003) Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage. J Biol Chem 278: 4561–4565. 53. Wang XQ, Yan Q, Sun P, Liu JW, Go L, et al. (2007) Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res 67: 9986–9995. 54. Gulbins E, Kolesnick R (2003) Raft ceramide in molecular medicine. Oncogene 22: 7070–7077. 55. Filosto S, Castillo S, Danielson A, Franzi L, Khan E, et al. (In press) Neutral Sphingomyelinase 2: A Novel Target in Cigarette Smoke-induced Apoptosis and Lung Injury. Am J Respir Cell Mol Biol. 56. Goni FM, Alonso A (2009) Effects of ceramide and other simple sphingolipids on membrane lateral structure. Biochim Biophys Acta 1788: 169–177. 57. Contreras FX, Villar AV, Alonso A, Kolesnick RN, Goni FM (2003) Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J Biol Chem 278: 37169–37174. 58. Kuebler WM, Yang Y, Samapati R, Uhlig S (2010) Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 26: 29–40. 59. Yang Y, Yin J, Baumgartner W, Samapati R, Solymosi EA, et al. (2010) Platelet- activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. Eur Respir J 36: 417–427. 60. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, et al. (2005) Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11: 491–498. 61. Petrache I, Natarajan V, Zhen L, Medler TR, Richter A, et al. (2006) Ceramide causes pulmonary cell apoptosis and emphysema: a role for sphingolipid homeostasis in the maintenance of alveolar cells. Proc Am Thorac Soc 3: 510. 62. Goldkorn T, Filosto S (2010) Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol 43: 259–268. 63. Becker KA, Grassme H, Zhang Y, Gulbins E (2010) Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis. Cell Physiol Biochem 26: 57–66. 64. Lurje G, Lenz HJ (2009) EGFR signaling and drug discovery. Oncology 77: 400–410. 65. Cai Z, Zhang H, Liu J, Berezov A, Murali R, et al. (2010) Targeting erbB receptors. Semin Cell Dev Biol. 66. Lieu C, Kopetz S (2010) The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy. Clin Colorectal Cancer 9: 89–94. 67. Egloff AM, Grandis JR (2008) Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer. Semin Oncol 35: 286–297. 68. Grassme H, Bock J, Kun J, Gulbins E (2002) Clustering of CD40 ligand is required to form a functional contact with CD40. J Biol Chem 277: 30289–30299. 69. Grassme H, Jendrossek V, Bock J, Riehle A, Gulbins E (2002) Ceramide-rich membrane rafts mediate CD40 clustering. J Immunol 168: 298–307. PLoS ONE | www.plosone.org 12 August 2011 | Volume 6 | Issue 8 | e23240